An institute whose experts have occupied key positions on EU and UN regulatory panels is, in reality, an industry lobby group that masquerades as a scientific health charity, according to a peer-reviewed study. The Washington-based International Life Sciences Institute (ILSI) describes its mission as pursuing objectivity, clarity and reproducibility" to "benefit the public good". But researchers from the University of Cambridge, Bocconi University in Milan, and the US Right to Know campaign assessed over 17,000 pages of documents under US freedom of information laws to present evidence of influence-peddling. The paper's lead author, Dr Sarah Steele, a Cambridge university senior research associate, said: "Our findings add to the evidence that this nonprofit organisation has been used by its corporate backers for years to counter public health policies. ILSI should be regarded as an industry group - a private body - and regulated as such, not as a body acting for the greater good." Around this time, ILSI was caught up in a separate controversy, when the Guardian revealed that ILSI Europe's vice-president Prof Alan Boobis chaired a UN panel that found glyphosate was probably not carcinogenic to humans. The final panel report included no conflict of interest statements, even though ILSI Europe had received donations of $500,000 (344,234) from Monsanto, which uses glyphosate in its RoundUp weedkiller, and $528,500 from its industry representative, Croplife International.